BE903168A - Nouveaux analogues 6-substitues de la mitomycine - Google Patents
Nouveaux analogues 6-substitues de la mitomycineInfo
- Publication number
- BE903168A BE903168A BE0/215534A BE215534A BE903168A BE 903168 A BE903168 A BE 903168A BE 0/215534 A BE0/215534 A BE 0/215534A BE 215534 A BE215534 A BE 215534A BE 903168 A BE903168 A BE 903168A
- Authority
- BE
- Belgium
- Prior art keywords
- new
- mitomycin analogs
- approximately
- substituted mitomycin
- substituted
- Prior art date
Links
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical class C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 title 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000002671 adjuvant Substances 0.000 abstract 1
- 125000005336 allyloxy group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 abstract 1
- QMRIWYCCTCNABA-UHFFFAOYSA-N indole-4,7-quinone Chemical compound O=C1C=CC(=O)C2=C1C=CN2 QMRIWYCCTCNABA-UHFFFAOYSA-N 0.000 abstract 1
- 230000001613 neoplastic effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Composition pharmaceutique pour le traitement d'une affection néoplasique chez un animal, qui comprend un solvant, diluant, adjuvant ou excipient pharmaceutiquement acceptable et, comme constituant actif, environ 0,4 mg à environ 12,8 mg d'un composé de formule I par exemple, le carbamate de 1,1a,2,8,8a,8b-hexahydro-8- (hydroxyméthyl) -8a-méthoxy-5-méthyl-6- (allyloxy) -azirino/2',3':3,4/pyrrolo/1,2-a/indole-4,7-dione.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/647,055 US4888341A (en) | 1984-09-04 | 1984-09-04 | 6-substituted mitomycin analogs |
Publications (1)
Publication Number | Publication Date |
---|---|
BE903168A true BE903168A (fr) | 1985-12-31 |
Family
ID=24595518
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE0/215534A BE903168A (fr) | 1984-09-04 | 1985-09-03 | Nouveaux analogues 6-substitues de la mitomycine |
Country Status (23)
Country | Link |
---|---|
US (1) | US4888341A (fr) |
JP (1) | JPS6168489A (fr) |
KR (1) | KR900006855B1 (fr) |
AT (1) | AT391318B (fr) |
AU (1) | AU593773B2 (fr) |
BE (1) | BE903168A (fr) |
CA (1) | CA1249278A (fr) |
CH (1) | CH666036A5 (fr) |
DE (1) | DE3531197A1 (fr) |
DK (1) | DK399985A (fr) |
ES (2) | ES8800225A1 (fr) |
FI (1) | FI81581C (fr) |
FR (1) | FR2569697B1 (fr) |
GB (1) | GB2164036B (fr) |
GR (1) | GR852066B (fr) |
HU (1) | HU194884B (fr) |
IT (1) | IT1203633B (fr) |
LU (1) | LU86059A1 (fr) |
NL (1) | NL8502203A (fr) |
NO (1) | NO162618C (fr) |
PT (1) | PT81084B (fr) |
SE (1) | SE468212B (fr) |
ZA (1) | ZA854452B (fr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4927943A (en) * | 1984-09-04 | 1990-05-22 | Bristol-Myers Company | Substituted 7-oxomitosanes |
US5097036A (en) * | 1984-09-04 | 1992-03-17 | Bristol-Myers Company | Substituted 7-oxomitosanes |
AU581673B2 (en) * | 1984-09-04 | 1989-03-02 | Bristol-Myers Company | Substituted 7-oxomitosanes |
CA1282069C (fr) * | 1985-09-12 | 1991-03-26 | Damon L. Meyer | Complexes d'anticorps comprenant des agents therapeutiques ou de diagnostic modifies par des haptenes |
EP0284380B1 (fr) * | 1987-03-25 | 1992-06-10 | Kyowa Hakko Kogyo Kabushiki Kaisha | Dérivés de mitomycine |
US5023253A (en) * | 1987-12-21 | 1991-06-11 | University Patents, Inc. | 6-substituted mitomycin analogs |
US5099016A (en) * | 1988-11-07 | 1992-03-24 | Bristol-Myers Company | Substituted 7-oxomitosanes |
DE69127345D1 (de) * | 1990-11-13 | 1997-09-25 | Kyowa Hakko Kogyo Kk | Mitomycinderivate |
DE10212359B4 (de) * | 2002-03-20 | 2005-10-06 | Peter Lisec | Verfahren und Vorrichtung zum maschinellen Applizieren eines Abstandhalterbandes auf eine Glasscheibe |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA770128A (en) * | 1967-10-24 | Matsui Masanao | 7-HYDROXY-9.alpha.-METHOXY MITOSANE AND PROCESS FOR PREPARING THE SAME | |
CA770608A (en) * | 1967-10-31 | Matsui Masanao | 1a-substituted mitomycin | |
US3306821A (en) * | 1962-09-04 | 1967-02-28 | Upjohn Co | Porfiromycin derivatives and method of making same |
NL132363C (fr) * | 1964-07-10 | |||
DE1570030A1 (de) * | 1964-07-11 | 1970-04-09 | Kyowa Hakko Kogyo Kk | Verfahren zur Herstellung von in 1a-Stellung substituierten Mitomycinverbindungen |
JPS5748985A (en) * | 1980-09-09 | 1982-03-20 | Kyowa Hakko Kogyo Co Ltd | Novel mitomycin derivative |
US4746746A (en) * | 1983-02-07 | 1988-05-24 | University Patents, Inc. | Mitomycin analogs |
US4803212A (en) * | 1983-04-11 | 1989-02-07 | Bristol-Myers Company | Amino disulfides |
US4814445A (en) * | 1984-09-04 | 1989-03-21 | Bristol-Myers Company | Process for preparing mitomycin analogs |
AU581673B2 (en) * | 1984-09-04 | 1989-03-02 | Bristol-Myers Company | Substituted 7-oxomitosanes |
-
1984
- 1984-09-04 US US06/647,055 patent/US4888341A/en not_active Expired - Fee Related
-
1985
- 1985-06-13 ZA ZA854452A patent/ZA854452B/xx unknown
- 1985-07-05 KR KR1019850004843A patent/KR900006855B1/ko not_active IP Right Cessation
- 1985-07-18 GB GB08518099A patent/GB2164036B/en not_active Expired
- 1985-07-23 AT AT0218185A patent/AT391318B/de not_active IP Right Cessation
- 1985-07-24 CA CA000487369A patent/CA1249278A/fr not_active Expired
- 1985-08-07 NL NL8502203A patent/NL8502203A/nl not_active Application Discontinuation
- 1985-08-07 AU AU45882/85A patent/AU593773B2/en not_active Ceased
- 1985-08-09 IT IT67722/85A patent/IT1203633B/it active
- 1985-08-19 FI FI853181A patent/FI81581C/fi not_active IP Right Cessation
- 1985-08-27 GR GR852066A patent/GR852066B/el unknown
- 1985-08-29 LU LU86059A patent/LU86059A1/fr unknown
- 1985-08-31 DE DE19853531197 patent/DE3531197A1/de not_active Withdrawn
- 1985-09-02 DK DK399985A patent/DK399985A/da not_active Application Discontinuation
- 1985-09-02 FR FR858513003A patent/FR2569697B1/fr not_active Expired - Fee Related
- 1985-09-03 NO NO853468A patent/NO162618C/no unknown
- 1985-09-03 PT PT81084A patent/PT81084B/pt not_active IP Right Cessation
- 1985-09-03 HU HU853336A patent/HU194884B/hu not_active IP Right Cessation
- 1985-09-03 ES ES546690A patent/ES8800225A1/es not_active Expired
- 1985-09-03 CH CH3790/85A patent/CH666036A5/de not_active IP Right Cessation
- 1985-09-03 JP JP60195692A patent/JPS6168489A/ja active Pending
- 1985-09-03 BE BE0/215534A patent/BE903168A/fr not_active IP Right Cessation
- 1985-09-04 SE SE8504113A patent/SE468212B/sv not_active IP Right Cessation
-
1987
- 1987-05-28 ES ES557566A patent/ES8800227A1/es not_active Expired
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE8102194L (sv) | Terapeutiskt aktiv organisk forening och farmaceutisk beredning innehallande denna | |
IL74631A (en) | 3-substituted 2-oxindole-1-carboxamides and pharmaceutical compositions containing them | |
CA2065285A1 (fr) | Compositions antimalariennes | |
MY102565A (en) | Novel derivatives of guanine | |
NO810478L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive substituerte imidazolderivater | |
NO155884C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazol-derivater. | |
BE903168A (fr) | Nouveaux analogues 6-substitues de la mitomycine | |
AU552908B2 (en) | 4 n-phenyl benzyl-aminomethyl-imidazole | |
US3624216A (en) | 8-substituted theophyllines as anti-inflammatory agents | |
ES528561A0 (es) | Un procedimiento para la preparacion de compuestos nitro alifaticos | |
EP0288962A3 (fr) | Ethers aryl-aralkyles, leurs procédés de préparation et composition pharmaceutique les contenant | |
DK454685D0 (da) | Pyrazolo(3,4-b)-pyridinamider | |
FR2444459A1 (fr) | Nouvelles poudres lyophilisees contenant un sel de l'acide thiazolidine-4-carboxylique utiles notamment comme agents anticancereux et leur procede de preparation | |
IL65787A (en) | Antiviral pharmaceutical compositions containing alpha,alpha-dialkyl-adamantylamines | |
OA08972A (fr) | Nouveaux dérivés N-(vinblastinoyl-23) d'acide amino-1 méthylphosphonique, leursprocédés de préparation et les compositions pharmaceutiques qui les contiennent | |
EP0652755A1 (fr) | Emploi therapeutique de phosphoryl-l-serine-n-acyl-sphingosine. | |
GR3001420T3 (en) | Prazosin-pirbuterol combination for bronchodilation | |
FR2447915A1 (fr) | Pyrimidin-4-yl-phosphorothionates, leur preparation et leur utilisation comme insecticides, acaricides et/ou nematocides | |
DE3664869D1 (en) | Pharmaceutical compositions of the prodrug type, a process for the preparation thereof, a process for the preparation of them as prodrug functioning compounds and compounds obtained therein | |
DE3372772D1 (en) | Quinazolinone derivatives, process for their preparation and their use in medicaments | |
SE8204791L (sv) | Sett att framstella alkoxivinkaminsyraestrar och alkoxiapovinkaminsyraestrar | |
MY100752A (en) | Pharmaceutical composition for combating malaria. | |
ATE26271T1 (de) | Benzhydrylpiperazine-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
JPS56115718A (en) | Physiologically active agent containing 2,3- dihydroxypropyl ester of n- 7-chloro-4-quinolyl anthranylic acid | |
JO1618B1 (en) | New Factors # 2 against a heart rhythm disorder |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RE | Patent lapsed |
Owner name: UNIVERSITY PARENTS INC. Effective date: 19960930 |